Shionogi & Co., Ltd. (TYO:4507)

Market Cap	2.27T
Revenue (ttm)	440.50B
Net Income (ttm)	179.12B
Shares Out	850.98M
EPS (ttm)	210.53
PE Ratio	12.67
Forward PE	12.49
Dividend	66.00 (2.48%)
Ex-Dividend Date	Sep 29, 2025

Volume	847,900
Average Volume	2,196,770
Open	2,684.50
Previous Close	2,666.50
Day's Range	2,610.00 - 2,684.50
52-Week Range	2,028.50 - 2,758.00
Beta	0.14
RSI	56.25
Earnings Date	Oct 27, 2025

About Shionogi &

Shionogi & Co., Ltd. researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices. It offers and develops drugs in the areas of infectious diseases, COVID-19, tumors, sclerosis, pomp, fragile X syndrome, and other diseases. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1878
• Employees: 4,955
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4507

Financial Performance

In 2024, Shionogi &'s revenue was 438.27 billion, an increase of 0.73% compared to the previous year's 435.08 billion. Earnings were 170.44 billion, an increase of 5.19%.